Explore our materials

International Hepatitis Cure & Eradication Meeting 2015

New Treatment in HCV: Is there need for more therapies? | Jordan Feld, MD, MPH

Harry Janssen

MD, PhD

International Hepatitis Cure & Eradication Meeting 2015

New Treatment Strategies for Hepatitis B | Harry Janssen, MD, PhD

Stephen Locarnini

BSc(Hons), PhD, MBBS, FRC(Path)

International Hepatitis Cure & Eradication Meeting 2015

New tools for testing and monitoring Hepatitis B and C | Stephen Locarnini, BSc(Hons), PhD, MBBS, FRC(Path)

John Ward

International Hepatitis Cure & Eradication Meeting 2015

Baby Boomer Screening in the U.S: Delivering on the promise thus far? | John Ward, MD

International Hepatitis Cure & Eradication Meeting 2015

Point-of-care (POC) testing in Hepatitis B and C | Scott Bowden, PhD

International Hepatitis Cure & Eradication Meeting 2015

Session 1 Panel Discussion

International Hepatitis Cure & Eradication Meeting 2015

A hepatitis C Vaccine: How do we prove it works? | Kimberly Page

International Hepatitis Cure & Eradication Meeting 2015

Hepatitis C Vaccines: Are we making progress? | Christopher M. Walker, PhD

Raymond Schinazi

PhD, DSc

International Hepatitis Cure & Eradication Meeting 2015

Rational pricing and the role of generics - Raymond Schinazi, PhD, DSc

Margaret Hellard

AM, MBBS, FRACP, FAFPHM, PhD

International Hepatitis Cure & Eradication Meeting 2015

Perspective from Medical Community - Margaret Hellard, AM, MBBS, FRACP, FAFPHM, PhD

International Hepatitis Cure & Eradication Meeting 2015

Perspective from Payers - Mel Krajden, MD, FRCPC & Bonnie Henry, MD, MPH, FRCPC